Highlights
ASX: MXC       MGC PHARMACEUTICALS LTD
Last Price Today's Change   Day's Range   Trading Volume
0.073   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):29,609,576
4 Weeks Range:0.06 - 0.087
4 Weeks Price Volatility (%):
83.91%
52 Weeks Range:0.036 - 0.12
52 Weeks Price Volatility (%):
60.83%
Average Price Target:-

Headlines

Date Subject
09-Jan-2017 MGC Pharmaceuticals secures European approval for derma products
02-Dec-2016 MGC Pharmaceuticals wins Czech order for cannabidiol based cosmetics

Business Background

MGC Pharmaceuticals Limited, formerly Erin Resources Limited, is a medical and cosmetics cannabis company. The Company is engaged in the creating cannabidiol (CBD) and medical cannabis business that focuses on the CBD market in Europe. CBD is used for the treatment of a range of skin and health conditions, including acne, psoriasis, eczema and dry skin. The Company's business model involves in growing cannabis sativa plants from high CBD yielding seeds and extracting CBD resin from the plants grown. It sells the CBD resins as a wholesale product to cosmetic and therapeutic product manufacturers. The CBD is also used to produce the Company's line of cosmetic products in Slovenia under the Ananda Cosmetics Joint Venture. It grows, harvests, dries out, extracts and sells cannabis sativa crop to enterprise customers in bulk, individual consumers in delivery devices or other products. The Company subsidiaries include MGC Pharma (UK) Ltd and MGC Pharmaceuticals d.o.o.

  Be the first to like this.
 


 

11144 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAC 1.3550.00 
 AAD 1.7550.00 
 DOWKOQ 0.7150.00 
 DOWKOT 2.800.00 
 AAJ 0.0140.00 
 PPTKOR 16.650.00 
 AAL 0.0050.00 
 AAR 0.080.00 
 NABKOJ 10.940.00 
 AAU 0.0090.00 
Partners & Brokers